Regeneron buys 23andMe for $256 million amid bankruptcy

Sage Kakkat

19 May 2025

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy.

Read Full Article →

PACENation Announces 2025 PACE Champions and PACESetters of the Year Awards

Venezuela Suspends Flights From Colombia To Prevent 'Entry Of Mercenaries'

Cookie Clicker Launches on Consoles: Now Available on Xbox, PlayStation, and Switch

Guess which ASX 200 technology stock has outperformed Nvidia over the past 5 years?

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.

Connect with us

World Trade Flash

Read more

PACENation Announces 2025 PACE Champions and PACESetters of the Year Awards

Venezuela Suspends Flights From Colombia To Prevent 'Entry Of Mercenaries'

Cookie Clicker Launches on Consoles: Now Available on Xbox, PlayStation, and Switch

Guess which ASX 200 technology stock has outperformed Nvidia over the past 5 years?